BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bian LF, Zheng C, Shi XL. Atezolizumab-induced anaphylactic shock in a patient with hepatocellular carcinoma undergoing immunotherapy: A case report. World J Clin Cases 2021; 9(16): 4110-4115 [PMID: 34141773 DOI: 10.12998/wjcc.v9.i16.4110]
URL: https://www.wjgnet.com/2307-8960/full/v9/i16/4110.htm
Number Citing Articles
1
Benjamin C. Park, Cosby A. Stone, Anna K. Dewan, Douglas B. Johnson. Hypersensitivity Reactions and Immune-Related Adverse Events to Immune Checkpoint Inhibitors: Approaches, Mechanisms, and ModelsImmunology and Allergy Clinics of North America 2022; 42(2): 285 doi: 10.1016/j.iac.2021.12.006
2
Atezolizumab/camrelizumab/lenvatinibReactions Weekly 2021; 1876(1): 63 doi: 10.1007/s40278-021-03312-6
3
Margarita Giraldo-Tugores, Carlos Fernández-Lozano, Alejandra Carrón-Herrero, Pablo Gajate, Javier Martinez-Botas, Cristina Pueyo-López, Emilio Solano-Solares, María Pilar Berges-Gimeno. Successful rapid desensitization to atezolizumab in delayed hypersensitivity confirmed with lymphocyte transformation testThe Journal of Allergy and Clinical Immunology: In Practice 2022; 10(6): 1649 doi: 10.1016/j.jaip.2021.12.041
4
A. Barroso, F. Estevinho, V. Hespanhol, E. Teixeira, J. Ramalho-Carvalho, A. Araújo. Management of infusion-related reactions in cancer therapy: strategies and challengesESMO Open 2024; 9(3): 102922 doi: 10.1016/j.esmoop.2024.102922
5
Guolong Zhang, Huiwen Weng, Yinghong Li, Pingdong Li, Yucui Gong, Jieya Chen, Lin Wei, Linghui Zeng, Yingchun Zeng, Andy SK. Cheng. Symptom clusters and their predictors in patients with lung cancer and treated with programmed cell death protein 1 immunotherapyAsia-Pacific Journal of Oncology Nursing 2022; 9(8): 100103 doi: 10.1016/j.apjon.2022.100103
6
Seung Hyuk Lee, Hyeon Jong Kim, Hyun Jin Bang, Su Ji Park, Ji Eun Yu, Seung Woo Jeong, Woo Kyun Bae. Case report: Pembrolizumab as an alternative to atezolizumab following a severe infusion reactionFrontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1273043